Skip to content
Institutional Investor Series A Series B Series C Series D clinical stage discovery stage company creation Est. 1985

SR One

Biotechnology venture capital firm investing in and building life science companies

📍 Redwood City, United States

About This Fund

Biotechnology venture capital firm investing in and building life science companies. It focuses on companies with strong fundamentals, clear development pathways, and novel approaches to disease treatment. The firm provides strategic partnership, leveraging its transatlantic presence to offer geographic reach and regional expertise, supporting portfolio companies' growth and development. This support includes business guidance and access to opportunities across various regions.

Investment Focus

Sectors
biotechnology life sciences therapeutics (oncology immunology rare diseases cardiometabolic neurodegenerative genetic medicines immuno-oncology)
Stages
Series A Series B Series C Series D clinical stage discovery stage company creation
Check Size $10M-$60M
Geography
USA UK

What They Look For

strong fundamentals, clearly defined development pathway, novel science addressing unmet medical needs; US/UK focus; innovative biotech companies

Preparing to pitch SR One?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →